The AJMC® Heart Failure compendium is a comprehensive resource for clinical news and expert insights for the chronic condition in which the heart doesn't pump enough blood due to damaged heart muscle.
AYAs With Advanced Heart Disease Prefer to Be Involved in Care Decisions
May 11th 2023Many adolescents and young adults (AYAs) with advanced heart disease prefer to be involved in decisions that have an impact on their medical care, but new survey results show there is a great need for educational communication efforts that involve their caregivers and clinicians.
Read More
Younger Women vs Men Have Worse Outcomes Following AMI
May 1st 2023This subanalysis of data from the VIRGO study encompassed 2979 patients who had an acute myocardial infarction (AMI), or heart attack, between ages 18 and 55 years; outcomes evaluated included all-cause and cause-specific acute events requiring hospitalization in the year after discharge for a heart attack.
Read More
Review Highlights Interventions to Address Therapeutic Gaps in Heart Failure Management
April 27th 2023Accelerating the safe implementation guideline-directed medical therapy has also been shown to reduce heart failure–related morbidity and mortality, underscoring the need for more integration into current care.
Read More
Hospitals Serving High Proportions of Black Patients Deliver Equivalent HF Care
April 21st 2023The investigators of this study wanted to know if hospitals that cared for a high proportion of Black patients delivered care for heart failure (HF) that differed in quality from that provided by other hospitals.
Read More
Sacubitril/Valsartan Likely to Improve Pre-HFpEF Outcomes vs Valsartan Alone
April 13th 2023At present, there are no approved therapies for pre–heart failure with preserved ejection fraction (pre-HFpEF); instead, cardiovascular risk factor management is often utilized in this patient population.
Read More
CVD Outcomes Investigation Highlights Need for More, Better Data on SDOH
March 29th 2023This study of the public health landscape in New York City investigated the interplay between social determinants of health (SDOH), chronic health conditions, and inequities in social factors, with a focus on cardiovascular disease (CVD).
Read More
Sacubitril/Valsartan in Medicare Alternative Payment Models
Optimizing utilization of sacubitril/valsartan for treatment of heart failure could improve provider performance in the Bundled Payments for Care Improvement initiative and the Medicare Shared Savings Program.
Read More
Dr Clyde Yancy: Redefine Greatness Through a Quest for Health Equity in Heart Failure
March 8th 2023Speaking at the 72nd American College of Cardiology Scientific Session in New Orleans on Sunday, Clyde W. Yancy, MD, MSc, the vice dean for diversity and inclusion at the Feinberg School of Medicine at Northwestern University, challenged the audience to rethink what success looks like in health care.
Read More
Results for the STELLAR trial, presented at the 72nd American College of Cardiology (ACC) Scientific Session Together With the World Congress of Cardiology, hit nearly every mark: patients taking sotatercept improved their performance on a 6-minute walk test by 40.8 meters, which was the primary end point, and achieved 8 of 9 secondary end points.
Read More
Bempedoic Acid, Approved to Treat LDL Cholesterol, Cuts Risk of Major CV Events by 13%
March 4th 2023Results from the CLEAR Outcomes trial were presented today at the 72nd American College of Cardiology (ACC) Scientific Session Together With the World Congress of Cardiology. Plans for a broader label are in the works.
Read More
Comparable Results Seen From Investigation of Torsemide vs Furosemide in HF
February 28th 2023Outcomes from the loop diuretics were compared in this analysis, with study participants from the TRANSFORM-HF trial matched 1:1, all having been hospitalized for either do novo disease or worsening chronic disease.
Read More
Postdischarge Telemonitoring, Telephone Coaching May Benefit Certain Patients With Heart Failure
February 17th 2023Patients with heart failure and high comorbidity burdens who received postdischarge noninvasive telemonitoring and nurse telephone coaching showed better survival outcomes than those who received standard care.
Read More
Sacubitril/Valsartan Safe, Effective for Patients With HFpEF Undergoing MHD
January 6th 2023The efficacy and safety of sacubitril/valsartan, the angiotensin receptor neprilysin inhibitor, was investigated among a patient population who had heart failure with preserved ejection fraction (HFpEF) and currently receiving maintenance hemodialysis (MHD).
Read More
ICYMI: Highlights From the 2022 AHA Scientific Sessions
December 15th 2022At this year’s American Heart Association (AHA) Scientific Sessions, held November 5-7 in Chicago, Illinois, hot topics for discussion included VICTORIA trial data and the great need for new antihypertensive agents to reduce health care disparities.
Read More
ICYMI: Top Highlights From ACC 2022
December 8th 2022The American College of Cardiology’s 71st Scientific Session covered how to address the impact of social determinants of health on cardiovascular outcomes, understanding the latest developments in digital health, and the role of COVID-19 on heart health.
Read More
Care Fragmentation Predicts 90-Day Durable Ventricular Assist Device Outcomes
This analysis evaluates the relationship between hospital care delivery network fragmentation and in-hospital and 90-day outcomes. These networks may be novel targets for improving outcomes.
Read More